Neuphoria Therapeutics In... (NEUP)
NASDAQ: NEUP
· Real-Time Price · USD
6.64
-0.18 (-2.58%)
At close: Jun 16, 2025, 3:59 PM
6.86
3.31%
After-hours: Jun 16, 2025, 07:36 PM EDT
-2.58% (1D)
| Bid | 6.53 |
| Market Cap | 12.48M |
| Revenue (ttm) | 15.66M |
| Net Income (ttm) | 5.74M |
| EPS (ttm) | 18.83 |
| PE Ratio (ttm) | 0.35 |
| Forward PE | -1.01 |
| Analyst | Strong Buy |
| Ask | 7.18 |
| Volume | 14,478 |
| Avg. Volume (20D) | 26,180 |
| Open | 6.95 |
| Previous Close | 6.82 |
| Day's Range | 6.60 - 6.95 |
| 52-Week Range | 2.12 - 12.55 |
| Beta | 0.46 |
About NEUP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NEUP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NEUP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
Neuphoria Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
3 weeks ago · https://www.marketscreener.com
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual MeetingBURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments fo...